Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections

2012 Eurosurveillance 378 citations

Abstract

We present a rigorously validated and highly sensitive confirmatory real-time RT-PCR assay (1A assay) that can be used in combination with the previously reported upE assay. Two additional RT-PCR assays for sequencing are described, targeting the RdRp gene (RdRpSeq assay) and N gene (NSeq assay), where an insertion/deletion polymorphism might exist among different hCoV-EMC strains. Finally, a simplified and biologically safe protocol for detection of antibody response by immunofluorescence microscopy was developed using convalescent patient serum.

Keywords

VirologyImmunofluorescenceAntibodyBiologyCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Molecular biologyMedicineImmunologyInfectious disease (medical specialty)Pathology

MeSH Terms

CoronavirusCoronavirus InfectionsFluorescent Antibody TechniqueGermanyHumansLaboratoriesPolymorphismRestriction Fragment LengthRNAViralReverse Transcriptase Polymerase Chain ReactionSensitivity and SpecificitySequence AnalysisDNAVirology

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
article
Volume
17
Issue
49
Citations
378
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

378
OpenAlex
31
Influential
247
CrossRef

Cite This

Victor M. Corman, Marcel A. Müller, Ulrich Costabel et al. (2012). Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Eurosurveillance , 17 (49) . https://doi.org/10.2807/ese.17.49.20334-en

Identifiers

DOI
10.2807/ese.17.49.20334-en
PMID
23231891

Data Quality

Data completeness: 86%